CACNA1A-related early-onset encephalopathy with myoclonic epilepsy: A case report

Takuya Hayashida1, Yoshiaki Saito1, Atsushi Ishii2

  • 1Division of Child Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago, Japan.

Brain & Development
|September 21, 2017
PubMed

Insights

A severe genetic epilepsy case in a one-year-old boy showed early-onset myoclonic epilepsy and developmental arrest. Genetic analysis revealed a CACNA1A gene mutation, indicating a severe form of early-onset encephalopathy.

Area of Science:

  • Genetics
  • Neurology
  • Pediatrics

Background:

  • Early-onset epilepsy poses significant challenges in diagnosis and management.
  • Developmental arrest and hyperekplexia are severe symptoms often associated with specific genetic conditions.

Observation:

  • A one-year-old boy presented with severe, refractory myoclonic/tonic seizures since birth, developmental arrest, and hyperekplexia.
  • Electroencephalography showed multifocal spikes and rhythmic activities correlating with myoclonus and tonic posturing.
  • Brain MRI revealed progressive cerebral atrophy, periventricular changes, and a thin corpus callosum.

Findings:

  • A de novo heterozygous missense mutation in the CACNA1A gene was identified as the cause.
  • This represents the most severe phenotype of CACNA1A-related early-onset encephalopathy reported to date.

Implications:

  • This case underscores the critical role of CACNA1A gene mutations in severe early-onset epileptic encephalopathies.
  • Understanding these severe phenotypes aids in diagnosis and potential therapeutic strategies for related neurological disorders.
  • Further research into CACNA1A-associated conditions is crucial for advancing pediatric epilepsy treatment.